PTH therapy in hypoparathyroidism has the potential to address aspects of the disease not ameliorated by conventional therapy. Both PTH(1-34) and PTH(1-84) have been demonstrated to lower or eliminate supplemental calcium and vitamin D requirements while maintaining serum calcium.